SourceBio International (FRA:6J8) Momentum Rank : 0 (As of Oct. 26, 2024)

View and export this data going back to 2020. Start your Free Trial

What is SourceBio International Momentum Rank?

SourceBio International has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

SourceBio International Momentum Rank Related Terms

Thank you for viewing the detailed overview of SourceBio International's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

SourceBio International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SourceBio International PLC (FRA:6J8) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Orchard Place, Nottingham Business Park, Nottingham, Nottinghamshire, GBR, NG8 6PX

Website

https://www.sourcebiointernational.com

SourceBio International PLC is an international provider of integrated laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries, with a focus on improving patient diagnosis, management and care. Its revenues are derived from four core businesses areas namely Healthcare Diagnostics; Genomics; Stability Storage; and Infectious Disease Testing. The offerings will provide a broad range of infectious disease testing across the NHS, private healthcare and commercial sectors in the future.

SourceBio International Headlines

No Headlines